Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > SH is upgrading their Bullboard protocols!!!,,Beware!!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(16)
•••
Post by narmacon Nov 20, 2022 3:12pm
237 Views
Post# 35114033

SH is upgrading their Bullboard protocols!!!,,Beware!!

SH is upgrading their Bullboard protocols!!!,,Beware!!
 
BULLYING
The 'Bullying' policy is new and will cover content that is used to intimidate or "push down" another member. Any repeated and persistent postings directed at another member for the sole purpose of attacking, insulting, or trolling a member will be removed. Some good spirited bantering is OK, after all that's part of the social contract, but anything that begins trolling or persistently targetting another member will be removed.
MULTIPLE ACCOUNTS
The 'Multiple Accounts' policy is new and will cover users that are attempting to sign up and use multiple accounts on Stockhouse. There is no good reason to have multiple accounts at Stockhouse other than to troll other members, game your own reputation, or as an attempt to circumvent suspensions of your account. If multiple accounts are identified the duplicates will be removed.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities